Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BTMD

biote Corp

Dec 11 • 04:00PM ET

6.67

Dollar change -0.08
Percentage change -1.19	%

Healthcare • Medical Care Facilities • USA • NASD

Peers: GNFT CORT XBIT BTAI TGTX KNSA AXSM VTGN ARDX MIRM

| Held by: IWM VTI VXF IWO DFAS VTWO FDM IWC EES VTWG

Scroll to Statements

Index	RUT	P/E	32.87	EPS (ttm)	0.20	Insider Own	8.16%	Shs Outstand	31.11M	Perf Week	1.21%
Market Cap	362.43M	Forward P/E	10.38	EPS next Y	0.64	Insider Trans	-0.99%	Shs Float	30.03M	Perf Month	16.00%
Income	10.04M	PEG	-	EPS next Q	0.11	Inst Own	67.48%	Short Float	2.29%	Perf Quarter	16.40%
Sales	193.06M	P/S	1.88	EPS this Y	84.62%	Inst Trans	11.06%	Short Ratio	4.35	Perf Half Y	0.60%
Book/sh	-4.19	P/B	-	EPS next Y	167.71%	ROA	8.00%	Short Interest	0.69M	Perf Year	22.61%
Cash/sh	0.70	P/C	9.48	EPS next 5Y	-	ROE	-	52W Range	3.65 - 8.44	Perf YTD	35.02%
Dividend Est.	-	P/FCF	10.29	EPS past 5Y	-19.96%	ROI	-	52W High	-20.97%	Beta	1.07
Dividend TTM	-	Quick Ratio	1.08	Sales past 5Y	14.07%	Gross Margin	68.00%	52W Low	82.55%	ATR (14)	0.34
Dividend Ex-Date	-	Current Ratio	1.50	EPS Y/Y TTM	260.06%	Oper. Margin	20.76%	RSI (14)	58.33	Volatility	4.08% 7.67%
Employees	194	Debt/Eq	-	Sales Y/Y TTM	4.84%	Profit Margin	5.20%	Recom	1.00	Target Price	9.54
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	36.73%	Payout	0.00%	Rel Volume	0.55	Prev Close	6.75
Sales Surprise	0.00%	EPS Surprise	180.85%	Sales Q/Q	12.79%	Earnings	Nov 12 AMC	Avg Volume	157.94K	Price	6.67
SMA20	3.80%	SMA50	16.34%	SMA200	7.61%	Trades		Volume	87,179	Change	-1.19%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-20-24	Initiated	B. Riley Securities	Buy	$9
Feb-01-24	Initiated	Jefferies	Buy
Jun-24-22	Initiated	Cowen	Outperform	$11
Jun-23-22	Initiated	ROTH Capital	Buy	$9

Dec-04-24 09:55AM	Does biote Corp. (BTMD) Have the Potential to Rally 43.89% as Wall Street Analysts Expect? (Zacks)
Nov-29-24 09:40AM	Are Investors Undervaluing biote Corp. (BTMD) Right Now? (Zacks)
Nov-22-24 09:55AM	biote Corp. (BTMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
Nov-18-24 08:00PM	Biote Corp (BTMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Enhancements (GuruFocus.com) +14.29%
09:55AM	Wall Street Analysts Predict a 76.99% Upside in biote Corp. (BTMD): Here's What You Should Know (Zacks)
09:40AM	Loading…
Nov-13-24 09:40AM	Is biote Corp. (BTMD) Stock Undervalued Right Now? (Zacks) +21.74%
09:00AM	AccessHope Expands Executive Leadership Team Amid Rapid Growth and Upcoming Market Expansion (PR Newswire)
Nov-12-24 06:15PM	Biote Corp. (BTMD) Beats Q3 Earnings Estimates (Zacks)
04:05PM	Biote Reports Third Quarter 2024 Financial Results (Business Wire)
Nov-11-24 07:19AM	Biote Corp (BTMD) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-01-24 09:55AM	Wall Street Analysts See an 88.04% Upside in biote Corp. (BTMD): Can the Stock Really Move This High? (Zacks)
Oct-29-24 04:05PM	Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call (Business Wire)
Oct-28-24 09:40AM	Is biote Corp. (BTMD) a Great Value Stock Right Now? (Zacks)
Aug-08-24 09:57PM	BTMD Stock Earnings: Biote Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace) -18.91%
04:05PM	Biote Reports Second Quarter 2024 Financial Results (Business Wire)
04:05PM	Loading…
Jul-25-24 04:05PM	Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call (Business Wire)
Jul-09-24 09:55AM	Wall Street Analysts Think biote Corp. (BTMD) Could Surge 25.44%: Read This Before Placing a Bet (Zacks) +5.55%
Jun-24-24 03:27AM	biote Corp. (BTMD) Surges 10.4%: Is This an Indication of Further Gains? (Zacks)
Jun-20-24 04:45PM	Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares (Business Wire) +10.44%
May-20-24 10:08AM	Biote Shares Fall After Report by Short-Seller J Capital (MT Newswires)
May-09-24 11:14AM	biote Corp. (PNK:BTMD) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 06:48AM	Q1 2024 Biote Corp Earnings Call (Thomson Reuters StreetEvents) +5.20%
May-07-24 09:56PM	BTMD Stock Earnings: Biote Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:50PM	Biote Corp. (BTMD) Q1 Earnings Beat Estimates (Zacks)
05:54PM	Biote Corp (BTMD) Q1 2024 Earnings: Performance Aligns with Analyst Revenue Projections (GuruFocus.com)
04:05PM	Biote Reports First Quarter 2024 Financial Results (Business Wire)
Apr-30-24 10:00AM	Earnings Preview: biote Corp. (BTMD) Q1 Earnings Expected to Decline (Zacks)
Apr-29-24 04:05PM	Biote Announces Definitive Settlement with Founder (Business Wire)
Apr-23-24 04:05PM	Biote Schedules First Quarter 2024 Financial Results Release and Conference Call (Business Wire)
Mar-13-24 08:37AM	biote Corp. (PNK:BTMD) Q4 2023 Earnings Call Transcript (Insider Monkey) +14.91%
06:11PM	Loading…
Mar-12-24 06:11PM	Biote Corp (BTMD) Reports Growth Amidst Challenges in Q4 and Full Year 2023 (GuruFocus.com)
04:05PM	Biote Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-05-24 10:00AM	Analysts Estimate biote Corp. (BTMD) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-27-24 04:05PM	Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call (Business Wire) +11.81% -5.76%
Feb-20-24 04:05PM	Biote Announces Agreement to Resolve Litigation and Repurchase All of Founders Shares (Business Wire) +7.13%
Jan-25-24 04:05PM	Biote Announces $20 Million Share Repurchase Authorization (Business Wire)
Jan-17-24 04:05PM	Biote to Purchase Asteria Health (Business Wire) -13.61%
04:05PM	Biote Provides Preliminary 2023 Results and Initial 2024 Guidance (Business Wire)
Jan-11-24 04:05PM	Biote Names Robert Peterson as Chief Financial Officer (Business Wire)
Nov-07-23 08:25PM	Biote Corp. (BTMD) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -23.75%
04:45PM	Biote Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-24-23 08:30AM	Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call (Business Wire)
Aug-10-23 06:40PM	Biote Corp. (BTMD) Beats Q2 Earnings and Revenue Estimates (Zacks) -13.43%
04:30PM	Biote Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-27-23 08:30AM	Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call (Business Wire)
Jul-13-23 09:29AM	12 Best Multibagger Penny Stocks To Buy (Insider Monkey)
Jun-22-23 07:00AM	Biote Formalizes Commitment to Mens Hormone Health With Launch of New Mens Health Division (Business Wire)
Jun-08-23 06:05PM	Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants (Business Wire)
Jun-05-23 07:48AM	Biote Announces Pricing of Secondary Offering of Common Stock (Business Wire)
May-31-23 08:30AM	Biote to Participate at Upcoming Investor Conferences (Business Wire)
May-30-23 08:30AM	Biote Appoints Mary J. Puncochar as Chief Commercial Officer (Business Wire)
May-09-23 05:21PM	Biote Reports First Quarter 2023 Financial Results (Business Wire) -7.25% -10.78%
05:21PM	Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants (Business Wire)
Apr-26-23 08:30AM	Biote Schedules First Quarter 2023 Financial Results Release and Conference Call (Business Wire)
Apr-10-23 08:30AM	Biote Names John Denne as General Manager, Mens Health Division (Business Wire)
Mar-31-23 09:55AM	Does biote Corp. (BTMD) Have the Potential to Rally 82.51% as Wall Street Analysts Expect? (Zacks) +9.36%
Mar-28-23 04:15PM	Biote Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire) +13.11%
Mar-27-23 09:00AM	Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report (Business Wire)
Mar-02-23 08:00AM	Biote to Present at 35th Annual Roth Conference (Business Wire)
Feb-09-23 04:15PM	Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call (Business Wire) -6.13%
Jan-09-23 05:30PM	Biote Announces Closing of Secondary Offering of 8,500,000 Shares of Common Stock Including Full Exercise of the Underwriters Over-Allotment Option (Business Wire) +11.94%
Jan-05-23 06:00AM	Biote Announces Pricing of Secondary Offering of Common Stock (Business Wire)
Nov-10-22 08:30AM	Biote to Present at Jefferies London Healthcare Conference (Business Wire)
Nov-08-22 04:15PM	Biote Reports Third Quarter Financial Results (Business Wire)
Nov-07-22 09:15AM	Biote Appoints Debby Morris to Board of Directors (Business Wire) -7.29%
Oct-31-22 08:30AM	Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call (Business Wire)
Oct-10-22 07:45AM	Biote Releases Updated Corporate Presentation for October 2022 (Business Wire)
Sep-07-22 08:30AM	Biote Announces Their Strategic Partnership with IMAC Holdings, Inc. (Business Wire)
08:30AM	Biote Announces Strategic Partnership with IMAC Holdings, Inc. (GlobeNewswire)
Aug-25-22 04:05PM	Biote Announces Approval to Relist on The Nasdaq Stock Market (Business Wire) -9.41%
Aug-24-22 08:30AM	Biote Appoints Samar Kamdar as Chief Financial Officer (Business Wire) +14.64%
Aug-15-22 04:56PM	Biote Issues Correction to Second Quarter Operating Loss and Net Income (Business Wire)
Aug-09-22 04:15PM	Biote Reports Second Quarter 2022 Financial Results (Business Wire)
Jul-20-22 11:00AM	Biote to Report Second Quarter 2022 Financial Results on August 9, 2022 and Host Conference Call on August 10, 2022 (Business Wire) -8.14%
Jul-18-22 10:24AM	How Much Of biote Corp. (NASDAQ:BTMD) Do Insiders Own? (Simply Wall St.) +7.56%
Jun-16-22 08:30AM	Biote Appoints Ross W. McQuivey, M.D. as Chief Medical Officer (Business Wire)
Jun-06-22 04:05PM	Biote Announces Participation in the Jefferies Healthcare Conference 2022 (Business Wire) -23.55%
08:16AM	National Women in the Workplace Survey: Women with Menopausal Symptoms Suffer in Silence in the Workplace (Business Wire)
Jun-03-22 08:59AM	Earnings growth of 806% over 1 year hasn't been enough to translate into positive returns for biote (NASDAQ:BTMD) shareholders (Simply Wall St.) +8.89%
May-26-22 04:05PM	Biote Debuts as Publicly Traded Company Focused on Transforming Hormone Optimization Industry (Business Wire) -9.07% -30.04%

biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company was founded in 2012 and is headquartered in Irving, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Peterson Robert Charles	Chief Financial Officer	Sep 09 '24	Sale	6.20	32,874	203,848	0	Sep 11 03:32 PM
Peterson Robert Charles	Chief Financial Officer	Jul 08 '24	Option Exercise	0.00	44,250	0	44,250	Jul 10 04:31 PM
Peterson Robert Charles	Chief Financial Officer	Jul 09 '24	Sale	7.57	11,376	86,084	32,874	Jul 10 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BTMD

biote Corp

Upgrade your FINVIZ experience